These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


3147 related items for PubMed ID: 15765032

  • 1. Diagnosis and treatment of pituitary adenomas.
    Chanson P, Salenave S.
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of pituitary adenomas].
    Mezosi E, Nemes O.
    Orv Hetil; 2009 Sep 27; 150(39):1803-10. PubMed ID: 19758960
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
    J Neurosurg; 2014 Dec 27; 121(6):1462-73. PubMed ID: 25237847
    [Abstract] [Full Text] [Related]

  • 4. Non-functioning pituitary adenomas.
    Chanson P, Brochier S.
    J Endocrinol Invest; 2005 Dec 27; 28(11 Suppl International):93-9. PubMed ID: 16625856
    [Abstract] [Full Text] [Related]

  • 5. Multiple pituitary hormone gradients from cavernous sinus sampling in patients with Cushing's disease.
    Yoshida Y, Sanno N, Teramoto A.
    Acta Neurochir (Wien); 2000 Dec 27; 142(12):1339-44. PubMed ID: 11214626
    [Abstract] [Full Text] [Related]

  • 6. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
    Clin Endocrinol (Oxf); 2004 Apr 27; 60(4):476-83. PubMed ID: 15049963
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and Treatment of Pituitary Adenomas: A Review.
    Molitch ME.
    JAMA; 2017 Feb 07; 317(5):516-524. PubMed ID: 28170483
    [Abstract] [Full Text] [Related]

  • 8. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy.
    Losa M, Fortunato M, Molteni L, Peretti E, Mortini P.
    Minerva Endocrinol; 2008 Dec 07; 33(4):329-40. PubMed ID: 18923369
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J, De Tribolet N, Déruaz JP, Janzer R, Uské A, Mirimanoff RO, Reymond MJ, Rey F, Temler E, Gaillard RC, Gomez F.
    Medicine (Baltimore); 1999 Jul 07; 78(4):236-69. PubMed ID: 10424206
    [Abstract] [Full Text] [Related]

  • 10. Radiation therapy in the multimodal treatment approach of pituitary adenoma.
    Becker G, Kocher M, Kortmann RD, Paulsen F, Jeremic B, Müller RP, Bamberg M.
    Strahlenther Onkol; 2002 Apr 07; 178(4):173-86. PubMed ID: 12040754
    [Abstract] [Full Text] [Related]

  • 11. [Thyrotropin--TSH secreting pituitary tumor].
    Zieliński G, Podgórski JK, Warczyńska A, Koziarski A, Zgliczyński W.
    Przegl Lek; 2002 Apr 07; 59(12):1018-23. PubMed ID: 12731380
    [Abstract] [Full Text] [Related]

  • 12. Thyroid-stimulating hormone pituitary adenomas.
    Clarke MJ, Erickson D, Castro MR, Atkinson JL.
    J Neurosurg; 2008 Jul 07; 109(1):17-22. PubMed ID: 18590428
    [Abstract] [Full Text] [Related]

  • 13. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
    Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A.
    Eur J Endocrinol; 2003 Apr 07; 148(4):433-42. PubMed ID: 12656664
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature.
    Minniti G, Esposito V, Piccirilli M, Fratticci A, Santoro A, Jaffrain-Rea ML.
    Eur J Endocrinol; 2005 Dec 07; 153(6):723-35. PubMed ID: 16322376
    [Abstract] [Full Text] [Related]

  • 15. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F, Grunenwald S, Vezzosi D, Rivière LD, Bennet A, Caron P.
    Thyroid; 2015 Aug 07; 25(8):877-82. PubMed ID: 26244412
    [Abstract] [Full Text] [Related]

  • 16. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A, Sanno N, Tahara S, Osamura YR.
    Acta Neuropathol; 2004 Aug 07; 108(2):147-53. PubMed ID: 15185102
    [Abstract] [Full Text] [Related]

  • 17. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U, Reichel M, Fett U, Saeger W, Quabbe HJ.
    J Clin Endocrinol Metab; 1994 Nov 07; 79(5):1416-23. PubMed ID: 7962337
    [Abstract] [Full Text] [Related]

  • 18. [Thyrotropin-secreting pituitary adenomas].
    Caron P.
    Presse Med; 2009 Jan 07; 38(1):107-11. PubMed ID: 18980829
    [Abstract] [Full Text] [Related]

  • 19. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
    Hofstetter CP, Shin BJ, Mubita L, Huang C, Anand VK, Boockvar JA, Schwartz TH.
    Neurosurg Focus; 2011 Apr 07; 30(4):E10. PubMed ID: 21456921
    [Abstract] [Full Text] [Related]

  • 20. Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
    Ferone D, Lastoria S, Colao A, Varrella P, Cerbone G, Acampa W, Merola B, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 1998 Jan 07; 83(1):248-52. PubMed ID: 9435450
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 158.